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Flavonoids and stilbenes have attracted much
attention as potential targets for nutraceuticals,
cosmetics, and pharmaceuticals. We have de-
veloped a system for producing ‘‘unnatural’’ fla-
vonoids and stilbenes in Escherichia coli. The
artificial biosynthetic pathway included three
steps. These included a substrate synthesis
step for CoA esters synthesis from carboxylic
acids by 4-coumarate:CoA ligase, a polyketide
synthesis step for conversion of the CoA esters
into flavanones by chalcone synthase and chal-
cone isomerase, and into stilbenes by stilbene
synthase, and a modification step for modifica-
tion of the flavanones by flavone synthase, fla-
vanone 3b-hydroxylase and flavonol synthase.
Incubation of the recombinant E. coli with exog-
enously supplied carboxylic acids led to pro-
duction of 87 polyketides, including 36 unnatu-
ral flavonoids and stilbenes. This system is
promising for construction of a larger library
by employing other polyketide synthases and
modification enzymes.
INTRODUCTION
Flavonoids are polyketide derivatives synthesized exclu-
sively in plants, many of which possess various functions,
such as acting as floral pigments, signal molecules, and
antimicrobial compounds [1]. In addition, several benefi-
cial effects on human health because of their antioxidant
[2], anti-inflammatory [3], antitumor [3], and estrogenic [4]
activities have been reported. Flavonoids are, therefore,
potential targets for nutraceuticals, cosmetics, and phar-
maceuticals. However, although more than 5000 flavo-
noids have been identified, their application has been
hampered because they usually exist as a mixture of mul-
tiple compounds and are difficult to isolate, or their activ-
ities are not satisfactory. Stilbenes, represented by resver-
atrol, are plant-derived polyketides that have also been
shown to prevent or slow the progression of a wide varietyChemistry & Biology 14, 6of diseases, including cancer, cardiovascular disease, and
ischemic injuries [5].
The biosynthesis of flavonoids starts with the naringenin
chalcone synthesis by chalcone synthase (CHS). Naringe-
nin chalcone is synthesized through the stepwise conden-
sation of three malonyl-CoAs onto p-coumaroyl-CoA by
CHS (Figure 1A). p-Coumaroyl-CoA as the substrate of
CHS is synthesized by thioesterification of p-coumaric
acid, which is generated from the phenylpropanoid path-
way with CoASH by 4-coumarate:CoA ligase (4CL). Narin-
genin chalcone is converted to (2S)-naringenin by intra-
molecular cyclization by chalcone isomerase (CHI), which
accomplishes the synthesis of a flavanone scaffold. All
flavonoids are produced from a common precursor,
(2S)-naringenin, through modifications by various tailoring
enzymes [6]. For instance, flavone synthase I (FNS I) syn-
thesizes apigenin from (2S)-naringenin and flavanone 3b-
hydroxylase (F3H) and flavonol synthase (FLS) sequen-
tially convert (2S)-naringenin into dihydrokaempferol and
kaempferol. FNS I, F3H, and FLS belong to the 2-oxoglu-
tarate-dependent oxygenases that are nonheme iron
dioxygenases utilizing 2-oxoglutarate as a cofactor [7].
2-Oxoglutarate-dependent oxygenases are soluble and
can therefore be functionally expressed in E. coli. We have
recently succeeded in microbial production of flavanone
[8], flavone, and flavonol [9] by reconstituting the flavonoid
biosynthetic pathway in E. coli.
Polyketides, including flavonoids and stilbenes, show a
great structural diversity. This structural diversity of poly-
ketide scaffolds is governed mainly by the selectivity of
starter and extender substrates, the number of condensa-
tion reactions, and the mode of ring closure of the resul-
tant polyketide chains [10]. Polyketides are synthesized
by polyketide synthases (PKSs) that fall into three groups,
types I through III [11]. Type I and type II PKSs are ketosyn-
thases with accessory enzymes that control the sizes and
shapes of the polyketide scaffolds [11]. In contrast, type III
PKSs, composed of only a ketosynthase domain, are
structurally the simplest PKSs that synthesize aromatic
polyketides by iterative condensation of malonyl-CoA de-
rivatives with acyl-CoA esters [12]. CHS, belonging to the
type III PKS superfamily, catalyzes condensation of p-
coumaroyl-CoA with three malonyl-CoA-derived acetate
units, intramolecular cyclization, and aromatization to pro-
duce naringenin chalcone (Figure 1A). Stilbene synthase13–621, June 2007 ª2007 Elsevier Ltd All rights reserved 613
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(A) Biosynthesis of flavanones and stilbenes in plants. These key intermediates are further modified into flavones and flavonols.
(B) The multiplasmid approach for synthesis of unnatural plant polyketides in E. coli. The polyketide synthesis is divided into three steps: substrate
synthesis from carboxylic acids by LE4CL-1, polyketide biosynthesis by CHS/CHI and STS, and modification by FNS and F3H/FLS.(STS), another representative of the type III PKS super-
family, uses the same substrates as CHS, but differs in the
ring folding, thus producing resveratrol, but not naringenin
chalcone (Figure 1A).
Recent development of ‘‘combinatorial biosynthesis’’
has enabled us to manipulate biosynthetic pathways to
generate a library of hybrid or unnatural compounds [10].
For example, 50 macrolides were prepared by systematic
modification of a modular type I PKS, 6-deoxyerythrono-
lide B synthase [13]. However, this approach cannot be
applied to the type III PKS. The diverse reactions of type
III PKSs depend on subtle differences in the amino acid
residues forming the active site cavity, since the polyke-
tide chain elongation, cyclization, and aromatization cata-
lyzed by type III PKSs occur in a single, multifunctional614 Chemistry & Biology 14, 613–621, June 2007 ª2007 Elsevieactive cavity formed by a homodimer of the ketosynthase
[12]. This structural simplicity has hampered systematic
exchange of functional domains or rational mutagenesis
for the synthesis of unnatural polyketides. Until now, the
reports concerning the synthesis of unnatural polyketides
by type III PKSs have been limited to in vitro synthesis de-
pending on the promiscuity of their substrate specificity
[14, 15].
However, plants produce a vast array of flavonoids that
are divided into nine major subgroups: chalcones, flava-
nones, flavones, flavonols, aurones, isoflavonoids, flava-
nediols, anthocyanins, and tannins [6]. This structural
diversity is generated through postpolyketide modifica-
tionsbyvarious tailoringenzymes [6].Therefore, in thecase
of type III PKSs, combinatorial biosynthesis for productionr Ltd All rights reserved
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could be established by means of combining various
PKSs and postpolyketide modification enzymes, rather
than systematic exchange of functional domains or ratio-
nal mutagenesis on the basis of their structure-function
relationship. In the present study, we have employed a
multiplasmid approach for producing unnatural plant poly-
ketides in E. coli by the combinatorial use of generous
substrate specificity of type III PKSs and a variety of
tailoring enzymes. A combination of the multiplasmid
approachwith precursor-directed biosynthesis has gener-
ated a library of natural and unnatural plant polyketide
compounds.
RESULTS AND DISCUSSION
Construction of Unnatural Polyketide
Production System
We divided the flavonoid biosynthetic pathway into three
steps: substrate synthesis, polyketide synthesis, andpost-
polyketide modification. These three steps were each
placed on a plasmid with different replication origins and
selectable markers and simultaneously introduced in
E. coli (Figure 1B). The plasmid for the substrate synthesis
step was pCDF-LE4CL-1 carrying the 4-coumarate:CoA
ligase gene from Lithospermum erythrohizon (gromwell)
on the vector pCDFDuet-1. Theplasmids for thepolyketide
synthesis step were pET-CHS/CHI, carrying the chalcone
synthase and chalcone isomerase genes from Glycyrrhiza
echinata (licorice) andPueraria lobata (kudzu), respectively,
on pETDuet-1, and pET-STS, carrying the stilbene syn-
thase gene fromArachis hypogaea (peanut) on pETDuet-1.
The plasmids for themodification stepwerepACYC-FNS I,
carrying the flavone synthase gene from Petroselinum
crispum (parsley) on pACYCDuet-1, and pACYC-F3H/
FLS, carrying the flavanone 3b-hydroxylase and flavonol
synthase genes from the Citrus plant genus on pACYC-
Duet-1. In addition to these plasmids, we also introduced
pRSF-ACC, carrying the two subunit genes for acetyl-
CoA carboxylase fromCorynebacterium glutamicum to in-
crease the intracellular pool ofmalonyl-CoA [8]. Thiswould
allow the efficient connection between the primary metab-
olism of E. coli and the secondary metabolisms that are
reconstituted by the plant genes.
The above system employed two techniques, a multi-
plasmid approach [16] and precursor-directed biosynthe-
sis [17]. One of the advantages of the multiplasmid
approach was that construction of recombinant biosyn-
thetic pathways by cotransformation of plasmids was
rapid and efficient, avoiding the laborious and time-con-
suming tasks required to construct plasmids for individual
biosynthetic steps [16]. Precursor-directed biosynthesis is
a promising approach to generating novel analogs of pol-
yketides. This technique was successfully applied to pro-
duction of novel polyketides by a type I PKS mutant that
was blocked in the early stage of the biosynthesis of a nat-
ural product [17]. Polyketide synthesis by the mutant en-
zyme was restored by the introduction of natural precur-
sors. Introduction of analogs of natural precursors, inChemistry & Biology 14, 6turn, gave novel compounds. To apply precursor-directed
biosynthesis to type III PKSs, we used E. coli as a host
where the phenyl propanoid pathway is absent. Conse-
quently, exogenous addition of unnatural carboxylic acids
to the recombinant E. coli cell would lead to production of
the corresponding CoA esters by the action of 4CLwithout
competition by the plant natural carboxylic acid, p-cou-
maric acid. CoA esters of unnatural carboxylic acidswould
be recognized as a starter substrate of CHS to give the
corresponding chalcones, which would be subsequently
converted to (2S)-flavanones by the intramolecular cycli-
zation activity of CHI (Figure 1B). STS, instead of CHS/
CHI, could be readily introduced to this systemby themul-
tiplasmid method, leading to the synthesis of unnatural
stilbenes. Another approach for the generation of molecu-
lar diversity by the present system is the introduction of
postpolyketide modification enzymes, FNS I and F3H/
FLS, which would convert the flavonoids into flavones
and flavonols, respectively (Figure 1B). A key to the suc-
cess of the precursor-directed biosynthesis by type III
PKSs is the recognition and processing of unnatural pre-
cursors and intermediates by the enzymes.
Combinatorial Biosynthesis of Unnatural
Plant Flavonoids
We first tried to produce natural and unnatural flavonoids
and stilbenes in a small scale in which 500 ml of the cell
suspension containing 40 g/l of glucose and 1 mM each
of the substrate carboxylic acids was incubated at 26C
for 60 hr. Since the cells were incubated in minimal me-
dium, and no cell mass increased during incubation [8,
9], detection and purification of the polyketides produced
were easily accomplished. In other words, the E. coli cell
was an enzyme bag that converted the carboxylic acids
into the corresponding flavonoids and stilbenes. For the
purpose of production of natural and unnatural flava-
nones, pCDF-LE4CL-1, pRSF-ACC, and pET-CHS/CHI
were simultaneously introduced in E. coli. As expected,
exogenous supply of natural carboxylic acids, such as cin-
namic acid (1a), p-coumaric acid (2a), m-coumaric acid
(3a), o-coumaric acid (4a), and caffeic acid (5a), to the
recombinant E. coli cells led to production of the corre-
sponding flavanones (1g–5g), as revealed by liquid chro-
matography electrospray ionization mass spectrometry
(LC-ESI/MS) and LC-ESI/MS/MS analysis (Figure 2; see
also Figure S1 in the Supplemental Data available with
this article online). In contrast, ferulic (6a) and sinapic
(7a) acids, which are natural carboxylic acids, were not
converted to flavanones, suggesting that the culture con-
ditions optimized for naringenin production from 2a were
not suitable for some carboxylic acids. It is known that
the optimal pH for flavanone formation is different among
the starter substrates [18].
We next added unnatural carboxylic acids to the re-
combinant E. coli cells. A variety of unnatural carboxylic
acids, such as fluorocinnamic acids (8a–11a), furyl (15a
and 17a), thienyl (16a and 18a), and naphthyl (20a) acrylic
acids, gave the corresponding unnatural flavanones
(8g–11g, 15g–18g, and 20g), which demonstrated the13–621, June 2007 ª2007 Elsevier Ltd All rights reserved 615
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The polyketides synthesized are surrounded by red squares. Novel compounds, which have not been reported in the literature, are indicated in blue.reliability and validity of the culture conditions (Figure 2,
Figure S1). Extracted ion LC-ESI/MS chromatograms
and LC-ESI/MS/MS fragmentation spectra of 8g are
shown in Figures 3B and 3E as representatives. Of the un-
natural flavanones produced, novel compounds that have
not been reported in the literature are shown in blue in Fig-616 Chemistry & Biology 14, 613–621, June 2007 ª2007 Elseviure 2. Roughly estimated, 50%of the product was present
in the culture broth, suggesting that the flavanones could
be readily transported through the cell membrane of
E. coli. We also detected negligible amounts of triketide
pyrones (1c–12c and 15c–18c), a typical derailment prod-
uct of type III PKSs, by the ion chromatograph analysis ofer Ltd All rights reserved
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Combinatorial Biosynthesis of Plant PolyketidesFigure 3. Extracted Ion LC-ESI/MSChro-
matograms and LC-ESI/MS/MS Frag-
mentation Spectra of 8g and 8f
(A) E. coli harboring pCDF-LE4CL-1, pRSF-
ACC, pETDuet-1, and pACYCDuet-1, as a
negative control, produced no flavanones.
The target ions of the extracted ion chromato-
grams are shown in the upper right of the chro-
matograms.
(B) Supplementation of 8a to E. coli harboring
pCDF-LE4CL-1, pRSF-ACC, pET-CHS/CHI,
and pACYCDuet-1 led to production of 8g.
(C) E. coli harboring pCDF-LE4CL-1, pRSF-
ACC, pETDuet-1, and pACYCDuet-1, as a
negative control, produced no stilbenes. The
target ions of the extracted ion chromatograms
are shown in the upper right of the chromato-
grams.
(D) Supplementation of 8a to E. coli harboring
pCDF-LE4CL-1, pRSF-ACC, pET-STS, and
pACYCDuet-1 led to production of 8f.
(E) The LC-ESI/MS/MS fragmentation spec-
trum of 8g.
(F) The LC-ESI/MS/MS fragmentation spec-
trum of 8f.LC-ESI/MS (data not shown). In all cases, no tetraketide
pyrones were detected.
We further introduced the plasmids for the modification
step into the E. coli cell expressing LE4CL-1, ACC, CHS,
and CHI.When pACYC-FNS I was introduced, 13 flavones
(1h–5h, 8h–11h, and 15h–18h) were synthesized from the
corresponding flavanones (Figure 2). An exception was
the flavanone (20g) derived from 3-(2-naphthyl) acrylic
acid, which was not modified by the FNS I. These findings
suggested that FNS I modified a broad spectrum of un-
natural flavanones (Figure 2, Figure S2). Similarly, the
F3H/FLS on pET-CHS/CHI also showed rather broad
substrate specificity, giving eight flavonols derived from
cinnamic, hydroxycinnamic, and monofluorocinnamic
acids (1i–5i and 8i–10i), albeit in small amounts (Figure 2,
Figure S3).
We scaled up the reactions starting from cinnamic acid
(1a), p-coumaric acid (2a), fluorocinnamic acid (8a), furyl-
(15a), and thienyl- (16a) acrylic acids to evaluate the pro-
ductivity of the system. The yields of the natural flavanones
derived from 1a and 2a reached roughly 70–90 mg/l and
those of the unnatural flavanones derived from 8a, 15a
and 16a reached ca. 50 to 100 mg/l (Table 1). In contrast,
the yields of natural (1c) and unnatural (16c) pyrones were
3.6 ± 1.1 and 2.7 ± 0.8 mg/l, respectively. These observa-
tions were consistent with the above-described in vitro
reaction of CHS that produced byproduct pyrones in small
amounts. Furthermore, theunnatural flavonesderived from
8a, 15a, and 16awere produced in yields of 30 to 50 mg/l,
whichwere comparable to the yields of the natural flavones
derived from 1a and 2a. These results showed that the
system was useful for production of novel polyketides.
However, the unnatural flavonols derived from 8a, 15a,
and 16awereproduced in trace amounts, and considerable
amountsof theflavanonesremained intact (datanotshown).Chemistry & Biology 14, 61We assume that no efficient conversion of the flavanones
to flavonols was due to the substrate preference of F3H,
because no dihydroflavonols were detected in the reaction.
Combinatorial Biosynthesis of Unnatural
Plant Stilbenes
We examined the feasibility of this approach by using STS
instead of CHS for the polyketide synthesis step. Exoge-
nous supply of carboxylic acids to the recombinant
E. coli cell containing 4CL, ACC, and STS resulted in the
production of 15 stilbenes (1f–5f, 8f–11f, 14f–19f) (Fig-
ure 2, Figure S4), which demonstrated that a type III
PKS other than CHS was applicable to this system. Ex-
tracted ion LC-ESI/MS chromatograms and LC-ESI/MS/
MS fragmentation spectra of 8f are shown in Figures 3D
Table 1. Yields of Plant Polyketides Produced by E. coli
Substrate
Flavanone
(mg/l)
Flavone
(mg/l)
Flavonol
(mg/l)
Stilbene
(mg/l)
1a 65 ± 7 33 ± 6 0.47 ± 0.08 155 ± 17
2a 87 ± 15 84 ± 14 33 ± 3 171 ± 17
8a 102 ± 16 30 ± 4 Trace 132 ± 26
15a 53 ± 30 26 ± 5 — 85 ± 44
16a 45 ± 25 46 ± 2 — 54 ± 3
Flavanones were isolated from E. coli harboring pCDF-
LE4CL-1, pRSF-ACC, pET-CHS/CHI, and pACYCDuet-1. Fla-
vones were isolated from E. coli harboring pCDF-LE4CL-1,
pRSF-ACC, pET-CHS/CHI, and pACYC-FNS. Flavonols
were isolated from E. coli harboring pCDF-LE4CL-1, pRSF-
ACC, pET-CHS/CHI, and pACYC-F3H/FLS. Stilbenes were
isolated from E. coli harboring pCDF-LE4CL-1, pRSF-ACC,
pET-STS, and pACYCDuet-1. Results are mean ± SE (n = 3).3–621, June 2007 ª2007 Elsevier Ltd All rights reserved 617
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STS converted the tetraketide intermediates derived
from 4-methylcinnamic acid (14a) and 3-(3-pyridyl) acrylic
acid (19a) into the corresponding stilbenes. On the other
hand, the tetraketide intermediate derived from naphthyl
acrylic acid (20a) was correctly ring-folded only by the
CHS. Besides stilbenes, negligible amounts of triketide
pyrones (1c–20c) and tetraketide pyrones (1d–5d, 8d–
12d, and 14d–20d) were observed by selected ion chro-
matography in LC-ESI/MS analysis (data not shown),
showing the occurrence of derailment reactions by the
STS. The yields of 1c and 16c were 2.8 ± 0.4 and 6.1 ±
2.2 mg/l, showing that STS produced byproduct pyrones
in trace amounts, as observed for CHS. The yields of stil-
benes derived from the unnatural carboxylic acids 8a,
15a, and 16a were 55–130 mg/l, which is comparable to
those of 130–170mg/l, derived from the natural carboxylic
acids, 1a and 2a (Table 1).
Bioactivity of Unnatural Plant Polyketides
Wemeasured CYP1B1 inhibitory activity of the plant poly-
ketides generated. CYP1B1, which catalyzes hydroxyl-
ation of 17b-estradiol, is a major enzyme for carcinogenic
estrogen metabolism and is thus involved in the meta-
bolic activation of procarcinogens [19]. Therefore, the
inhibition of CYP1B1 is an attractive oncological thera-
peutic strategy [19]. The ethoxyresorufin-O-deethylase
(EROD) activity is commonly used to test the activity of
CYP1B1. We first measured the inhibitory activity of ethyl-
acetate extracts of the E. coli cells producing polyketides
(flavonoids and stilbenes) against the EROD activity of
CYP1B1 and compared them with that of a negative con-
trol, an ethylacetate extract of the E. coli cells harboring
pCDF-LE4CL-1, pRSF-ACC, pETDuet-1, and pACYC-
Duet-1. Note that this primary test was just to screen for
candidates having CYP1B1-inhibitory activity, because
the amounts of the polyketides and probable byproducts
were not taken into consideration. As a result, besides the
natural polyketides produced from 1a to 5a, the polyketi-
des from 8a to 11a and 16a to 19a appeared to show
CYP1B1 inhibitory activity (data not shown). We chose
and purified five stilbenes (1f, 2f, 8f, 15f, and 16f) as rep-
resentatives to confirm that the CYP1B1-inhibitory activ-
ity detected in the ethylacetate extracts was actually
due to the stilbenes produced and for further analysis
of the inhibition kinetics (Table 2). The results obtained
with purified stilbenes showed that the unnatural stil-
benes (8f, 15f, and 16f) had distinct CYP1B1 inhibition
kinetics similar to those of the natural stilbenes (1f and
2f). This result suggested that the bioactivity of unnatural
polyketides was comparable to that of natural products,
and that a library of unnatural products would be promis-
ing as a source for screening of bioactive compounds of
various functions.
Further Insight into Combinatorial Biosynthesis
Although several attempts to develop a system for pro-
duction of plant polyketides have been reported [8, 9,
20–24], these studies were concentrated on the produc-618 Chemistry & Biology 14, 613–621, June 2007 ª2007 Elsevition of natural products. In this study, we have developed
a system for producing variants of plant polyketides by
recombinant E. coli. This newly developed system allowed
the synthesis of 87 polyketides (14 flavanones, 13 fla-
vones, 8 flavonols, 15 stilbenes, and 37 pyrones), includ-
ing 36 novel compounds. In addition, our findings suggest
that the relaxed substrate specificity of FNS I enables us
to synthesize unnatural flavones, whereas the substrate
preference of F3H was a bottleneck for the synthesis
of unnatural flavonols. It may be possible to overcome
this bottleneck by random or systematic mutagenesis of
F3H. Furthermore, the positive clones that contain mu-
tated F3H with broader substrate specificity can be easily
selected by substituting the part of F3H in pACYC-F3H/
FLS in E. coli harboring pCDF-LE4CL-1, pRSF-ACC, and
pET-CHS/CHI, in addition to the substituted plasmid,
and examining production of unnatural flavonols. A similar
procedure would be possible for screening of novel
enzymes, such as type III PKSs and flavonoid-tailoring
enzymes with broader substrate specificity, from plant
and microbial origins.
The yields of the unnatural plant polyketides were com-
parable to those of the natural polyketides. The yields of
flavanones and stilbenes were approximately 50–150
mg/l, and those of flavones were 30–80 mg/l. This means
that the flavanones are efficiently converted to the corre-
sponding flavones, indicating rather broad substrate
specificity of the FNS. On the other hand, most flavonols,
except for 2i and 5i (Figure S2), were produced in small
amounts. We assume that the low yields of the flavonols
were due to strict substrate specificity of the F3H, be-
cause no accumulation of dihydroflavonols was observed.
Notwithstanding the low yields of flavonols, the system in
this study is useful in the high-yield production of natural
and unnatural flavanones, stilbenes, and flavones. The
present system is convenient in the purification of the
products, because they are produced in minimal medium,
Table 2. Inhibition of the EROD activity of CYP1B1 by
Stilbenes
Inhibitora Vmax (pmol/mg/min)
b KM (mM)
c Ki (mM)
d
— 885 0.315 —
1f 377 0.158 0.0743
2f 565 0.232 0.177
8f 676 0.276 0.323
15f 610 0.270 1.11
16f 621 0.262 1.18
Ki, inhibitor constant; KM, Michaelis constant; Vmax, maximum
velocity.
a The concentrations of inhibitors are described in Experimen-
tal Procedures.
bMaximum velocity of the EROD activity by CYP1B1.
cMichaelis constant of ethoxyresorufin.
d Ki was calculated from the equation, 1/Vmax
0 = (1/Vmax0)(1 +
[I]/Ki). Vmax0 indicates Vmax without an inhibitor, Vmax
0 indicates
Vmax with an inhibitor, and [I] indicates the concentration of an
inhibitor.er Ltd All rights reserved
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phenylpropanoid-flavonoid pathway is absent in E. coli,
the present system is free from background reactions that
would result in the formation of undesirable byproducts. In
plants, polyketides are usually produced as a mixture of
more than 20 derivatives [25–27], making the purification
step very laborious.
There are various polyketide biosynthesis enzymes that
could readily be applied to the present system employing
the multiplasmid approach; for instance, propionyl-CoA
carboxylase giving methylmalony-CoA [28] would provide
different extender substrates for polyketide synthesis. Re-
cently discovered type III PKSs that possess novel cata-
lytic activities, such as benzalacetone synthase [29], could
provide different polyketide scaffolds. In addition, several
flavonoid-modifying enzymes, including methylase [30]
and prenyl transferase [31], were identified. Applying not
only these enzyme genes, but also many enzyme genes
of plant and microbial origin, to this system would enable
us to produce a wide variety of natural and unnatural
polyketides.
SIGNIFICANCE
Flavonoids show various bioactivities beneficial to hu-
man health, such as antioxidant [2], anti-inflammatory
[3], antitumor [3], and estrogenic [4] activities. Stil-
benes, representated by resveratrol, are reported to
prevent cancer, cardiovascular disease, and ischemic
injuries [5]. Therefore, establishment of a system for
rapid, efficient production of flavonoids and stilbenes
has been desired. The bacterial system that we have
constructedbyemploying type III polyketidesynthases
(PKSs) and a variety of tailoring enzymes is a rapid and
efficient one, and is convenient for purification of the
products. This system has also proven useful in pro-
duction of unnatural flavonoids and stilbenes. Of the
natural and unnatural polyketides produced by this
system,somemayshowpotentandnovelbioactivities.
This report describes a convenient and efficient
system for production of unnatural flavonoids and stil-
benes bymicroorganisms. A combination of combina-
torial biosynthesis and precursor-directed biosyn-
thesis resulted in production of 14 flavanones, 13
flavones, 8 flavonols, and 15 stilbenes. Simultaneous
production of 20 triketide pyrones and 17 tetraketide
pyrones were also observed. Of the 70 plant polyketi-
des produced in this way, 36were novel products. This
production system allowed the high-yield production
of both natural and unnatural plant polyketides. Sev-
eral stilbenes produced by this system showed inhibi-
tion against the ethoxyresorufin-O-deethylase activity
of CYP1B1, suggesting that novel, unnatural polyketi-
des become potential bioactive compounds. Thus, the
present study opens up the possibility of producing
novel compounds by combinatorial biosynthesis
employing type III PKSs and a variety of tailoring en-
zymes. Various enzymes of plant and microbial origin
that can be readily incorporated as members in theChemistry & Biology 14, 61artificial biosynthetic pathway would contribute to
construction of a larger library of natural and unnatural
polyketides.
EXPERIMENTAL PROCEDURES
Materials
E. coli strains JM109 and BLR (DE3), pUC19, restriction enzymes, T4
DNA ligase, Taq DNA polymerase, and other DNA-modifying enzymes
were purchased from Takara Biochemicals. pETDuet-1, pRSFDuet-1,
pACYCDuet-1, and pCDFDuet-1 were purchased from Novagen. p-
Coumaric acid (2a), sinapic acid (7a), 4-fluorocinnamic acid (8a), 3,4-
difluorocinnamic acid (11a), 3,5-difluorocinnamic acid (12a), 4-methyl-
cinnamic acid (14a), 3-(3-furyl)-acrylic acid (15a), 3-(3-thienyl)-acrylic
acid (16a), 3-(3-pyridyl)-acrylic acid (19a), chrysin (1h), and galangin
(1i) were purchased from Aldrich. 3-Fluorocinnamic acid (9a) was pur-
chased from Alfa Aesar. 3-(2-Naphthyl)-acrylic acid (20a) was pur-
chased from Oakwood products. Caffeic acid (5a), ferulic acid (6a),
and naringenin (2g) were purchased from Sigma. Cinnamic acid (1a),
m-coumaric acid (3a), o-coumaric acid (4a), 2-fluorocinnamic acid
(10a), 3-(2-furyl)-acrylic acid (17a), 3-(2-thienyl)-acrylic acid (18a), and
apigenin (2h) were purchased fromWako. Resveratrol (2f) and kaemp-
ferol (2i) were purchased from Extrasynthesis. Pinocembrin (1g) was
purchased from Indofine Chemical Company. 3-(4-Biphenylyl)-acrylic
acid (13a) was purchased from Avocado Research Chemicals. Human
CYP1B1 + P450 Reductase SUPERSOMES were purchased from BD
Bioscience.
Construction of Plasmids
pACYC-F3H/FLS [9], pACYC-FNS I [9], and pRSF-ACC [8] have been
described previously. To construct pET-CHS/CHI carrying the CHS
and CHI genes under the control of the T7 promoter, we first con-
structed pET-CHI. With the pET-PT7-4GS [8] as a template, the 1.1 kb
DNA fragment containing the CHI-coding region was amplified by
PCR with primer I: 50-GGAATTCCATATGGCGGCAGCAGCAGCAGT-
30 (with an EcoRI site shown in bold, an NdeI site shown by underlining,
and the start codon of CHI shown in italics) and primer II: 50-CG
GGATCCTCAGACTATAATGCCGTGGC-30 (with a BamHI site shown
by underlining and the stop codon of CHI shown in italics). The ampli-
fied fragment was cloned between the EcoRI and BamHI sites of
pUC19, resulting in pUC19-CHI. The NdeI-BamHI fragment containing
the CHI sequence was excised from pUC19-CHI and cloned between
the NdeI and BglII sites of pETDuet-1, resulting in pET-CHI. With the
pET-PT7-4GS as a template, the 1.1 kb DNA fragment containing the
CHS-coding region was amplified by PCR with primer III: 50-CGG
AATTCCCATGGTGAGCGTAGCTGAGAT-30 (with anEcoRI site shown
in bold, an NcoI site shown by underlining, and the start codon of CHS
shown in italics) and primer IV: 50-CGGGATCCTCAGATGGCCACACT
ACGCA-30 (with a BamHI site shown in bold and the stop codon ofCHS
shown in italics). Theamplified fragmentwasclonedbetween theEcoRI
and BamHI sites of pUC19, resulting in pUC19-CHS. The NcoI-BamHI
fragment containing theCHS sequencewas excised frompUC19-CHS
and cloned between the NcoI and BamHI sites of pET-CHI, resulting
in pET-CHS/CHI. For construction of pET-STS containing a cDNA of
STS (AB027606) fromA. hypogaea, the NcoI-BamHI fragment contain-
ing the STS sequence on pET-3d-STS [32] was excised and cloned
between the NcoI-BamHI sites of pETDuet-1, resulting in pET-STS.
For construction of pCDF-LE4CL-1, carrying the 4CL gene from
L. erythrorhizon, the 1.1 kbDNA fragment containing theLE4CL-1-cod-
ing region was amplified by PCR with primer V: 50-ACATGCATGCCC
ATGGGGATGGACACTCAAACCAAAAC-30 (with an SphI site shown
in bold, an NcoI site shown by underlining, and the start codon of
LE4CL-1 shown in italics) and primer VI: 50-CGCGGATCCCTAATTGTG
ATCACCATTTGCAA-30 (with a BamHI site shown by underlining and
the stop codon of 4CL shown in italics). The amplified fragment was
cloned between the SphI and BamHI sites of pUC19, resulting in
pUC19-LE4CL-1. The NcoI-BamHI fragment containing the LE4CL-13–621, June 2007 ª2007 Elsevier Ltd All rights reserved 619
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NcoI and BamHI sites of pCDFDuet-1, resulting in pCDF-LE4CL-1.
Production of Plant Polyketides by E. coli
Ampicillin (100 mg/ml), kanamycin (50 mg/ml), chloramphenicol (34 mg/
ml), and streptomycin (50 mg/ml) were used, when necessary. Re-
combinant E. coli BLR (DE3) cells were precultured overnight at 37C
in 2 ml of Luria-Bertani (LB) medium. The preculture was transferred
into 100 ml of LB medium and cultured at 26C until the optical density
at 600 nm reached 0.6. Isopropyl b-D-thiogalactopyranoside (IPTG)
was then added at a final concentration of 1 mM, and the culture was
further continued for 5 hr. The cells were harvested by centrifugation
and the cells (0.5 gwetweight) were suspended in 20ml ofM9medium.
To a portion (500 ml) of the cell suspension inM9 (25 g/l wet weight) was
added 1 mM each of substrates, 40 g/l glucose, 25 g/l CaCO3, 0.5 mM
FeSO4$2H2O, antibiotics, and 1 mM IPTG, and the culture was incu-
bated at 26C for 60 hr. The culture broth was adjusted to pH 3.0
with 6 N HCl. After extraction with an equal volume of ethyl acetate,
materials were concentrated by evaporation and dissolved in 100 ml
dimethyl sulfoxide for LC-ESI/MS/MS analysis. LC-ESI/MS/MS was
performed in a positivemodeonan esquireHCTplus (Bruker Daltonics)
equippedwith a DOCOSIL-B column (C22, 23 200mm; Senshu Scien-
tific Co.), and the sample was eluted with a gradient of acetonitrile in
water (both containing 0.1% acetic acid) at a flow rate of 0.2 ml/min.
The conditions of the gradient were: 20% CH3CN for 5 min and 20%–
100% CH3CN for 40 min. UV spectra were detected on an Agilent
1100 series UV detector.
For estimation of the amounts of the polyketides produced, the cul-
ture was performed with 20 ml medium. The yields were estimated on
the basis of the standard curve obtained by integration of the area of
the UV peak of the authentic sample on aWaters 600E-996 HPLC sys-
tem equipped with a DOCOSIL-B column (C22, 4.6 3 250 mm; Sen-
shu). The authentic sample was eluted with a gradient of acetonitrile
in water (both containing 0.1% trifluoroacetic acid) at a flow rate of
1.0 ml/min. The conditions of the gradient were: 10%–50% CH3CN
for 40 min and 50%–100% for 5 min. For the authentic samples, com-
mercially available polyketides and NMR spectroscopically pure flava-
nones (8g, 15g, and 16g), flavones (8h, 15h, and 16h), stilbenes (1f, 8f,
15f, and 16f), and triketide pyrones (1c and 16c) were used to prepare
the calibration curves.
Characterization of Flavanones
The extracted ion chromatograms of LC-ESI/MS are shown in Fig-
ure S1. 8g, 15g, and 16g were chosen as representatives for NMR
spectroscopic studies, and were prepared from a 200ml scale M9 cul-
ture, described above. The flavanones were purified by reversed-
phase preparative HPLC equipped with a DOCOSIL-B column (C22,
20 3 250 mm; Senshu) by elution with 50% of CH3CN in water. 5,7-
Dihydroxy-2-(4-fluorophenyl)-chroman-4-one (8g) 1H NMR (500 MHz,
CDCl3): d = 7.43 (dd, 2H, J = 5.5, 8.5 Hz), 7.12 (t, 2H, J = 8.5 Hz),
6.01 (d, 1H, J = 2.0 Hz), 5.99 (d, 1H, J = 2.0 Hz), 5.41 (dd, 1H, J = 3.5,
13.0 Hz), 3.05 (dd, 1H, J = 13.0, 17.5 Hz), 2.81 (dd, 1H, J = 3.5, 17.5 Hz).
5,7-Dihydroxy-2-(3-furyl)-chroman-4-one (15g) 1H NMR (500 MHz,
CDCl3): d = 7.51 (s, 1H), 7.45 (s, 1H), 6.49 (s, 1H), 5.99 (d, 1H, J =
2.0 Hz), 5.97 (d, 1H, J = 2.0 Hz), 5.43 (dd, 1H, J = 3.5, 13.5 Hz), 3.02
(dd, 1H, J = 13.5, 17.5 Hz), 2.87 (dd, 1H, J = 3.5, 17.5 Hz). 5,7-Dihy-
droxy-2-(3-thienyl)-chroman-4-one (16g) 1H NMR (500 MHz, CDCl3):
d = 7.39 (dd, 1H, J = 3.0, 5.0 Hz), 7.36 (br, 1H), 7.68 (dd, 1H, J = 1.0,
5.0 Hz), 6.01 (d, 1H, J = 2.0 Hz), 6.00 (d, 1H, J = 2.0 Hz), 5.51 (dd, 1H,
J = 3.5, 12.0 Hz), 3.09 (dd, 1H, J = 12.0, 17.0 Hz), 3.00 (dd, 1H, J = 3.5,
17.0 Hz). We identified the other flavanones by comparing the MS/MS
fragmentation patterns with those of authentic naringenin (2g). The
LC-ESI/MS/MS analysis of flavanones revealed the two major positive
fragments, which are characteristic of flavanones (Figure S5).
Characterization of Flavones
The extracted ion chromatograms of LC-ESI/MS are shown in
Figure S2. The NMR spectra of representatives are: 5,7-dihydroxy-620 Chemistry & Biology 14, 613–621, June 2007 ª2007 Elsevie2-(4-fluorophenyl)-chromen-4-one (8h) 1H NMR (500 MHz CDCl3): d =
7.89 (dd, 2H, J = 5.5, 9.0 Hz), 7.22 (t, 2H, J = 9.0 Hz), 6.65 (s, 1H),
6.46 (d, 1H, J = 2.5 Hz), 6.30 (d, 1H, J = 2.5 Hz). 5,7-Dihydroxy-2-(3-
furyl)-chromen-4-one (15h) 1H NMR (500 MHz CD3OD): d = 8.29 (m,
1H), 7.68 (m, 1H), 6.93 (m, 1H), 6.47 (s, 1H), 6.41 (d, 1H, J = 2.0 Hz),
6.18 (d, 1H, J = 2.0 Hz). 5,7-Dihydroxy-2-(3-thienyl)-chromen-4-one
(16h) 1H NMR (500 MHz CD3OD): d = 8.26 (m, 1H), 7.62 (m, 2H), 6.62
(s, 1H), 6.46 (d, 1H, J = 2.0 Hz), 6.21 (d, 1H, J = 2.0 Hz). The other flava-
nones were characterized by comparing the MS/MS fragmentation
patterns with those of authentic apigenin (2h). The LC-ESI/MS/MS
analysis of flavones revealed the two major positive fragments, which
are characteristic of flavanones (Figure S5).
Characterization of Flavanols
The extracted ion chromatograms of LC-ESI/MS are shown in Fig-
ure S3. The flavonols were characterized by comparing the MS/MS
fragmentation patterns with those of authentic galangin (1i) and
kaempferol (2i). The LC-ESI/MS/MS analysis of flavonols revealed the
two specific positive fragments, which are characteristic to flavanones
(Figure S5).
Characterization of Stilbenes
The extracted ion chromatograms of LC-ESI/MS are shown in Fig-
ure S4. The NMR spectra of representatives are: 5-styrylbenzene-
1,3-diol (1f) 1H NMR (500 MHz, CD3OD): d = 7.50 (d, 2H, J = 7.0 Hz),
7.32 (t, 2H, J = 7.0 Hz), 7.22 (t, 1H, J = 7.0 Hz), 7.03 (d, 1H, J = 16.0
Hz), 6.98 (d, 1H, J = 16.0 Hz), 6.48 (d, 2H, J = 2.0 Hz), 6.18 (t, 1H,
J = 2.0 Hz). 5-[2-(4-Fluorophenyl)-vinyl]benzene-1,3-diol (8f) 1H NMR
(500 MHz, CDCl3): d = 7.52 (dd, 2H, J = 8.5, 5.5 Hz), 7.06 (t, 2H, J =
8.5 Hz), 7.02 (d, 1H, J = 16 Hz), 6.93 (d, 1H, J = 16 Hz), 6.47 (d, 2H,
J = 2.0 Hz), 6.18 (t, 1H, J = 2.0 Hz). 5-[2-(3-Furyl)-vinyl]benzene-1,3-
diol (15f) 1H NMR (500 MHz, CD3OD): d = 7.60 (s, 1H), 7.46 (s, 1H),
6.91 (d, 1H, J = 16.0 Hz), 6.71 (s, 1H), 6.68 (d, 1H, J = 16.0 Hz), 6.41 (d,
2H, J = 2.0 Hz), 6.15 (t, 1H, J = 2.0 Hz). 5-[2-(3-Thienyl)-vinyl]benzene-
1,3-diol (16f) 1HNMR (500MHz, CD3OD): d = 7.37 (m, 2H), 7.06 (m, 1H),
7.06 (d, 1H, J = 16.5 Hz), 6.83 (d, 1H, J = 16.5 Hz), 6.44, (d, 2H, J = 2.0
Hz), 6.16 (t, 1H, J = 2.0 Hz). The other stilbenes were characterized by
comparing the MS/MS fragmentation patterns with those of authentic
resveratrol (2f), except for 19f. The LC-ESI/MS/MS analysis of flavones
revealed a positive fragment, which is characteristic of stilbenes (Fig-
ure S5); 19f was identified only by LC-ESI/MS analysis (Figure S4).
Characterization of Triketide Pyrones
4-Hydroxy-6-styrylpyran-2-one (1c) 1H NMR (500 MHz, [CD3]2CO): d =
7.67 (d, 2H, J = 7.5 Hz), 7.42 (t, 2H, J = 7.5 Hz), 7.39 (d, 1H, J = 16.5 Hz),
7.36 (t, 1H, J = 7.5 Hz), 6.94 (d, 1H, J = 16.5 Hz), 6.23 (s, 1H), 5.42
(s, 1H). 6-(2-Furan-3-yl-vinyl)-4-hydroxypyran-2-one (16c) 1H NMR
(500 MHz, [CD3]2CO): d = 7.77 (d, 1H, J = 3.0 Hz), 7.54 (dd, 1H, J = 3.0,
5.0 Hz), 7.49 (dd, 1H, J = 1.0, 5.0 Hz), 7.43 (d, 1H, J = 16 Hz), 6.78 (d,
1H, J = 16 Hz), 6.14 (s, 1H), 5.38 (s, 1H).
EROD Assay
The EROD assay was performed as described previously [33]. Briefly,
the standard reaction contained 7.5 mg of CYP1B1, 7.5 mg bovine se-
rum albumin, 115 mMNADPH, 110 mMNADH, 5mMMgSO4, and 0.1M
HEPES (pH 8.0) in a total volume of 100 ml. The stilbenes were added
at a final concentration of 0.1 mM (1f, 2f, and 8f) or 0.5 mM (15f and 16f).
The ethylacetate extracts (0.1 mg/ml) of E. coli were used. After 2 min
of incubation at 37C, ethoxyresorufin (0.05, 0.1, 0.2, 0.3, 0.4, and
0.6 mM for kinetic analyses and 2 mM for ethylacetate extract samples)
was added to initiate the reaction. After 10 or 20 min, 50 ml of methanol
was added to stop the reaction. Resorufin was quantified with a fluo-
rescence plate reader (excitation and emission, 530 and 590 nm,
respectively).
Supplemental Data
Supplemental Data, including five additional figures, are available
online at http://www.chembiol.com/cgi/content/full/14/6/613/DC1/.r Ltd All rights reserved
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